C07D

Watch

Stats

Description

HETEROCYCLIC COMPOUNDS

Subclasses

Not Available
Subclass Title
201/00 Preparation, separation, purification, or stabilisation of unsubstituted lactams
201/02 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams
201/04 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement
201/06 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from or via oximes by Beckmann rearrangement from ketones by simultaneous oxime formation and rearrangement
201/08 Preparation, separation, purification, or stabilisation of unsubstituted lactams Preparation of lactams from carboxylic acids or derivatives thereof, e.g. hydroxy carboxylic acids, lactones, nitriles

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
9999612 PPARs agonist activity enhancing drug Sep 09, 16 Jun 19, 18 , TSUJIMOTO CHEMICAL CO., LTD.
9999680 Conjugates comprising cell-binding agents and maytansinoids as cytotoxic agents Feb 28, 14 Jun 19, 18 , Immunogen Inc.
9999878 Tin-containing zeolitic material having a BEA framework structure Nov 05, 14 Jun 19, 18 , BASF SE
9999673 PEGylated lipids and their use for drug delivery Jan 11, 12 Jun 19, 18 , Alnylam Pharmaceuticals Inc.
9999624 Combination Alzheimer therapy using anti-N3pGlu Abeta antibodies + a BACE inhibitor Sep 08, 15 Jun 19, 18 , Eli Lilly and Company
9999615 Autotaxin inhibitor compounds Sep 09, 16 Jun 19, 18 , PHARMAKEA, INC.
9999620 CaMKK-β as a target for treating cancer Jun 17, 16 Jun 19, 18 , Duke University
9994443 Modified nicotinic compounds and related methods Nov 04, 11 Jun 12, 18 , Selecta Biosciences, Inc.
9994532 Bis-isoxazole tetranitrate (BITN): a high-energy propellant plasticizer and melt-castable eutectic explosive ingredient Aug 25, 17 Jun 12, 18 , The United States of America as represented by the Secretary of the Army
9993480 mTOR/JAK inhibitor combination therapy Feb 17, 12 Jun 12, 18 , Novartis Pharma AG; Incyte Corporation;
9993477 Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitors Mar 08, 17 Jun 12, 18 , H - Lundbeck A/S
9993463 Use of maleimide derivatives for preventing and treating cancer Dec 10, 13 Jun 12, 18 , CENTOGENE AG
9994589 Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy Dec 13, 16 Jun 12, 18 , Amicus Therapeutics, Inc.
9993459 Selective HDAC6 inhibitors and uses thereof Jan 07, 16 Jun 12, 18 , Universiteit Gent
9993479 Trk-inhibiting compound Aug 17, 17 Jun 12, 18 , Ono Pharmaceutical Co. Ltd.
9994542 Prodrugs of urolithins and uses thereof Dec 23, 14 Jun 12, 18 , Amazentis SA
9994565 Kinase inhibitors Dec 22, 16 Jun 12, 18 , Chiesi Farmaceutici S.p.A
9994521 Therapeutic compounds and compositions Oct 11, 16 Jun 12, 18 , EXITHERA PHARMACEUTICALS INC.
9994518 Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof Jun 11, 15 Jun 12, 18 , Merck Sharp & Dohme Corp.
9994519 Synthetic antioxidants and their uses Apr 18, 13 Jun 12, 18 , Not available

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2018/0170,918 METHODS OF SYNTHESIZING A DIFLUOROLACTAM ANALOG Jan 30, 18 Jun 21, 18 , Not available
2018/0170,855 TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF Jun 14, 16 Jun 21, 18 , Not available
2018/0170,898 BETA- AND GAMMA-AMINO-ISOQUINOLINE AMIDE COMPOUNDS AND SUBSTITUTED BENZAMIDE COMPOUNDS Dec 15, 17 Jun 21, 18 , Not available
2018/0170,824 METHODS FOR PRODUCING CYCLIC AND ACYCLIC KETONES Mar 23, 15 Jun 21, 18 , The Regents of the University of California; BP Corporation North America Inc.;
2018/0170,924 PI-KINASE INHIBITORS WITH ANTI-INFECTIVE ACTIVITY Feb 09, 18 Jun 21, 18 , Not available
2018/0170,899 LIGHT EMITTING MATERIAL, MANUFACTURE METHOD THEREOF AND ORGANIC LIGHT EMITTING DIODE USING THE LIGHT EMITTING MATERIAL Aug 12, 16 Jun 21, 18 , Not available
2018/0170,923 COMPOUNDS FOR THE TREATMENT OF CANCER Dec 21, 17 Jun 21, 18 , Hoffmann-La Roche, Inc.
2018/0170,892 COMPOUND FOR THE PROPHYLAXIS OR TREATMENT OF ORGAN DAGAMAGE May 12, 16 Jun 21, 18 , SULFATEQ B.V.
2018/0170,883 HSP70 MODULATORS AND METHODS FOR MAKING AND USING THE SAME Dec 14, 17 Jun 21, 18 , Not available
2018/0170,869 BENZENESULFONAMIDE DERIVATIVES AS INVERSE AGONISTS OF RETINOID-RELATED ORPHAN RECEPTOR GAMMA (ROR GAMMA (T)) Dec 18, 15 Jun 21, 18 , Not available
2018/0168,166 Isolated Bacterial Strain of the Genus Burkholderia and Pesticidal Metabolites Therefrom Jan 30, 18 Jun 21, 18 , Not available
2018/0170,939 BICYCLIC DIHYDROPYRIMIDINE-CARBOXAMIDE DERIVATIVES AS RHO- KINASE INHIBITORS Dec 21, 17 Jun 21, 18 , CHIESI FARMACEUTISI S.p.A.
2018/0170,916 INHIBITORS OF CXCR2 Oct 02, 17 Jun 21, 18 , Not available
2018/0170,874 HETEROCYCLIC COMPOUND Apr 19, 16 Jun 21, 18 , Not available
2018/0170,928 Methyl- and Trifluoromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof Feb 06, 18 Jun 21, 18 , Pfizer Inc.
2018/0170,876 NOVEL HISTONE DEACETYLASE INHIBITORS Aug 02, 17 Jun 21, 18 , Not available
2018/0175,305 AZAAZENE ANALOGUES AND THEIR USE AS SEMICONDUCTOR Mar 20, 15 Jun 21, 18 , Not available
2018/0170,949 SYNTHESIS OF CEPHALOSPORIN COMPOUNDS Dec 18, 15 Jun 21, 18 , Merck Sharp & Dohme Corp.
2018/0170,931 Small Molecule Inhibitors of the JAK Family of Kinases Dec 15, 17 Jun 21, 18 , Not available
2018/0170,913 MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT Dec 28, 17 Jun 21, 18 , AstraZeneca AB

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of watches () for this membership level. Upgrade to our Level for up to watches!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to watch the Technologies/Sub-Technologies.